Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NPIPA3 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
mRNA | RNF115 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
mRNA | SLC4A1 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
mRNA | NPTN | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
mRNA | ANKS1A | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
mRNA | LAMB1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | RBBP6 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
mRNA | LMCD1 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
mRNA | TTLL2 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
mRNA | ENOX1 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |